BUZZ-CERo Therapeutics jumps on US FDA's 'fast track' tag for cancer therapy
Reuters
Sep 05
BUZZ-CERo <a href="https://laohu8.com/S/LENZ">Therapeutics</a> jumps on US FDA's 'fast track' tag for cancer therapy
** Shares of drug developer CERo Therapeutics CERO.O rise 11% to $7.65 premarket
** Co says its experimental blood cancer therapy, CER-1236, received U.S. FDA's "fast track" tag
** FDA's "fast track" tag aims to speed development and review of drugs for serious conditions with unmet medical need
** The therapy is being tested in an early stage trial for patients with aggressive forms of acute myeloid leukemia, a type of blood and bone marrow cancer
** Stock down 94% YTD
(Reporting by Kamal Choudhury in Bengaluru)
((Kamal.Choudhury@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.